medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 10, 2024
Abstract
Major
depressive
disorder
(MDD)
is
characterized
by
changes
in
appetite
and
body
weight
as
well
blunted
reward
sensitivity
(“anhedonia”).
However,
it
not
understood
which
mechanisms
are
driving
sensitivity,
specifically
regarding
food.
Here,
we
used
a
sample
of
117
participants
(54
patients
with
MDD;
63
healthy
control
participants,
HCP)
who
completed
food
cue
reactivity
(FCR)
task
ratings
wanting
liking
for
60
20
non-food
items.
To
evaluate
components
the
may
contribute
to
altered
depression,
tested
associations
macronutrients
depicted
In
line
previous
studies,
found
reduced
(
p
=
.003),
but
.23)
MDD
compared
matched
HCPs.
Adding
macronutrient
composition
models
substantially
improved
their
fit
s
<
.001).
Compared
carbohydrate-rich
foods,
reported
lower
high-fat
high-protein
foods.
Moreover,
showed
weaker
correlations
preferences
carbohydrate-versus
fat-
or
protein-rich
foods
.001),
pointing
potential
disturbances
metabolic
signaling.
conclude,
our
results
suggest
that
depression-related
alterations
more
specific
than
previously
anticipated,
hinting
at
gut-brain
These
findings
raise
intriguing
question
whether
interventions
targeting
gut
could
help
normalize
aberrant
signals
rich
fat
protein.
Figure
Neuroscience & Biobehavioral Reviews,
Journal Year:
2024,
Volume and Issue:
unknown, P. 105990 - 105990
Published: Dec. 1, 2024
The
rising
prevalence
of
treatment-resistant
neuropsychiatric
disorders
underscores
the
need
for
innovative
and
effective
treatment
strategies.
gut
microbiota
(GM)
plays
a
pivotal
role
in
progression
these
diseases,
influencing
brain
mental
health
through
gut-brain
axis
(GBA).
vagus
nerve
significant
GBA,
making
it
key
area
focus
potential
novel
therapeutic
interventions.
Vagus
stimulation
(VNS)
was
introduced
approved
as
refractory
forms
some
neuropsychological
disorders,
such
depression
epilepsy.
Considering
its
impact
on
several
regions
that
play
vital
part
mood,
motivation,
affection,
cognitive
function,
VNS
has
shown
treating
variety
disorders.
Harnessing
to
target
bidirectional
communication
pathways
linking
GM
VN
could
present
an
exciting
approach
Imbalances
GM,
dysbiosis,
can
impair
between
brain,
contributing
development
shows
modulating
interconnected
systems,
helping
restore
balance.
Interestingly,
composition
may
also
influence
effectiveness
VNS,
modify
brain's
response
this
approach.
This
study
provides
comprehensive
analysis
relatively
unexplored
but
noteworthy
interaction
In
addition,
we
discussed
mechanisms,
potential,
clinical
implications
GBA
across
Psychological Medicine,
Journal Year:
2025,
Volume and Issue:
55
Published: Jan. 1, 2025
Abstract
Major
depressive
disorder
(MDD)
is
characterized
by
changes
in
appetite
and
body
weight
as
well
blunted
reward
sensitivity
(‘anhedonia’).
However,
it
not
understood
which
mechanisms
are
driving
sensitivity,
specifically
regarding
food.
Here,
we
used
a
sample
of
117
participants
(54
patients
with
MDD
63
healthy
control
[HCPs])
who
completed
food
cue
reactivity
task
ratings
wanting
liking
for
60
20
non-food
items.
To
evaluate
components
the
may
contribute
to
altered
depression,
tested
associations
macronutrients
depicted
In
line
previous
studies,
found
reduced
(
p
=
.003)
but
.23)
compared
matched
HCPs.
Adding
macronutrient
composition
models
substantially
improved
their
fit
s
<
.001).
Compared
carbohydrate-rich
foods,
reported
lower
high-fat
high-protein
foods.
Moreover,
showed
weaker
correlations
preferences
carbohydrate-
versus
fat-
or
protein-rich
foods
.001),
pointing
potential
disturbances
metabolic
signaling.
conclude,
our
results
suggest
that
depression-related
alterations
more
specific
than
previously
anticipated,
hinting
at
gut–brain
These
findings
raise
intriguing
question
whether
interventions
targeting
gut
could
help
normalize
aberrant
signals
rich
fat
protein.
Frontiers in Electronics,
Journal Year:
2025,
Volume and Issue:
6
Published: Feb. 6, 2025
Recent
advances
in
manufacturing
of
flexible
and
conformable
microelectronics
have
opened
opportunities
for
health
monitoring
disease
treatment.
Other
material
engineering
advances,
such
as
the
development
conductive,
skin-like
hydrogels,
liquid
metals,
electric
textiles,
piezoelectric
films
provide
safe
comfortable
means
interfacing
with
human
body.
Together,
these
enabled
design
bioelectronic
devices
integrated
multimodal
sensing
stimulation
capabilities
to
be
worn
nearly
anywhere
on
Of
particular
interest
here,
external
ear
(auricle)
offers
a
unique
opportunity
scalable
high
degree
usability
familiarity
given
broad
use
headphones.
This
review
article
discusses
recent
auricular
capable
physiological
biochemical
sensing,
cognitive
monitoring,
targeted
neuromodulation,
control
human-computer
interactions.
Stemming
from
this
foundation,
there
will
increased
growth
competition
research
advance
bioelectronics.
activity
lead
adoption
smart
headphone-style
by
patients
consumers
tracking
health,
treating
medical
conditions,
enhancing
Frontiers in Human Neuroscience,
Journal Year:
2025,
Volume and Issue:
19
Published: March 6, 2025
A
growing
number
of
research
studies
have
explored
the
potential
effects
vagus
nerve
stimulation
(VNS)
on
brain
physiology
as
well
clinical
particularly
related
to
stress
and
anxiety.
However,
there
currently
are
limited
showing
functional
changes
during
different
frequencies
laterality
transcutaneous
auricular
VNS
(TaVNS).
In
this
study,
we
evaluated
whether
TaVNS
alters
connectivity
in
healthy
controls.
We
hypothesized
that
would
significantly
alter
areas
involved
with
emotional
processing
regulation
including
limbic
areas,
insula,
frontal
lobe
regions,
cerebellum.
enrolled
50
Participants
were
placed
MRI
scanner
compatible
ear
buds
provided
TaVNS.
Subjects
underwent
left,
right,
both
ears
a
randomized
manner
session.
Stimulation
was
for
5
min
then
off
period
between.
To
evaluate
primary
outcome
neurophysiological
effects,
all
participants
received
blood
oxygen
level
dependent
(BOLD)
magnetic
resonance
imaging
(fMRI)
states.
The
results
demonstrated
significant
differed
depending
frequency
which
stimulated.
general,
had
altered
included
frontoparietal
Interestingly,
cognitive
also
parts
temporal
lobe,
salience
network,
default
mode
network.
This
study
is
an
initial
step
toward
understanding
associated
findings
indicate
changes,
regulation,
cognition.
Future
can
expand
data
focus
specific
patient
populations
determine
Psychiatry and Clinical Neurosciences Reports,
Journal Year:
2025,
Volume and Issue:
4(1)
Published: March 1, 2025
Abstract
Anhedonia
is
a
transdiagnostic
domain
that
leads
to
poor
disorder
outcome
and
low
remission
rates.
This
narrative
review
describes
broad
range
of
interventions
targeting
anhedonia,
including
pharmacological,
neuromodulatory,
behavioral,
lifestyle‐based
approaches.
Drugs
such
as
vortioxetine,
agomelatine,
bupropion,
ketamine,
brexpiprazole
show
promising
anti‐anhedonic
effects,
while
traditional
antidepressants,
serotonin‐norepinephrine
reuptake
inhibitors
(SNRIs)
and,
even
more
so,
selective
serotonin
(SSRIs),
are
less
effective.
Neuromodulation
techniques,
repetitive
transcranial
magnetic
stimulation,
direct
current
transcutaneous
auricular
vagus
nerve
proved
effective
at
improving
particularly
when
used
in
targeted
areas.
Psychotherapeutic
interventions,
behavioral
activation,
mindfulness‐based
strategies,
savoring
also
help
re‐engage
patients
with
pleasurable
activities
enhance
positive
affect.
Innovative
treatments,
aticaprant
psilocybin,
showed
results.
Substantial
evidence
suggests
anhedonia
better
psychosocial
functioning,
quality
life,
sustained
remission.
Although
most
data
come
from
short‐term
studies,
several
long‐term
analyses
suggest
maintaining
hedonic
improvements
feasible
beneficial.
The
reviewed
underscores
the
importance
routine
assessment
integration
symptom‐specific
strategies.
Tailoring
address
individual
patterns
reward
disruption
may
optimize
outcomes
for
anhedonia.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 3, 2024
Abstract
Transcutaneous
vagus
nerve
stimulation
(tVNS)
has
emerged
as
a
promising
technique
to
modulate
autonomic
functions,
and
pupil
dilation
been
recognized
biomarker
for
tVNS-induced
monoaminergic
release.
Nevertheless,
studies
on
the
effectiveness
of
various
tVNS
protocols
have
produced
heterogeneous
results
dilatation
date.
Here,
we
synthesize
existing
evidence
compare
conventional
continuous
pulsed
using
Bayesian
meta-analysis.
To
maintain
living
version,
developed
Shiny
App
with
possibility
incorporate
newly
published
in
future.
Based
systematic
review,
included
18
(N
=
771)
applying
either
or
protocols.
Across
studies,
found
anecdotal
alternative
hypothesis
that
increases
size
(
g
0.14,
95%
CI
[0.001,
0.29],
BF01
2.5).
Separating
according
vs.
revealed
were
driven
by
taVNS
(strong
hypothesis:
0.34,
[0.15,
0.53],
BF10
14.15)
while
provided
strong
null
0.01,
[-0.15,
0.16],
BF01=
20.7).
In
conclusion,
our
meta-analysis
highlights
differential
effects
dilation.
These
findings
underscore
relevance
optimizing
its
use
specific
applications
may
require
modulation
tonic
phasic
responses.
Frontiers in Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: Nov. 13, 2024
Non-invasive
vagus
nerve
stimulation
(VNS)
represents
a
transformative
approach
for
managing
broad
spectrum
of
inflammatory
and
autoimmune
conditions,
including
rheumatoid
arthritis
bowel
disease.
This
comprehensive
review
delineates
the
mechanisms
underlying
VNS,
emphasizing
cholinergic
anti-inflammatory
pathway,
explores
interactions
within
neuro-immune
vagus-gut
axes
based
on
both
clinical
outcomes
pre-clinical
models.
Clinical
applications
have
confirmed
efficacy
VNS
in
specific
diseases,
such
as
arthritis,
chronic
conditions
like
disease,
showcasing
variability
parameters
patient
responses.
Concurrently,
studies
provided
insights
into
potential
modulating
cardiovascular
broader
responses,
paving
way
its
translational
application
settings.
Innovations
non-invasive
technology
precision
neuromodulation
are
enhancing
therapeutic
potential,
making
it
viable
option
patients
who
unresponsive
to
conventional
treatments.
Nonetheless,
widespread
adoption
this
promising
therapy
is
impeded
by
regulatory
challenges,
compliance
issues,
need
extensive
long-term
safety.
Future
research
directions
will
focus
refining
technology,
optimizing
treatment
parameters,
exploring
synergistic
effects
with
other
modalities,
which
could
revolutionize
management
disorders.
IEEE Journal of Biomedical and Health Informatics,
Journal Year:
2024,
Volume and Issue:
28(10), P. 5962 - 5970
Published: July 4, 2024
Transcutaneous
auricular
vagus
nerve
stimulation
(taVNS)
is
an
emerging
neuromodulation
technology
that
has
been
reported
to
be
beneficial
in
the
treatment
of
diseases
by
several
studies,
but
its
exact
mechanism
action
still
unclear.
It
demonstrated
taVNS
can
influence
interoceptive
signals.
Notably,
processing
signals
directly
related
many
diseases,
such
as
depression,
anxiety,
and
insomnia.
The
insula
medial
prefrontal
cortex
(MPFC)
communicate
during
bottom-up
transmission
taVNS-induced
signals,
both
play
a
role
signal
processing.
By
focusing
on
MPFC,
our
research
pioneers
detail
potential
interactions
between
effects
taVNS,
providing
novel
insights
into
neurobiological
mechanisms
taVNS.
Two
functional
connectivity
(FC)
analyses
(region
interest-based
seed-based)
were
used
this
study.
We
observed
negative
MPFC
was
significantly
weakened
following
while
there
no
statistical
changes
sham
group.
Our
findings
elucidate
linking
vagal
activity
with
intrinsic
FC
among
specific
brain
regions
networks.
Specifically,
results
indicate
may
enhance
ability
flexibly
balance
awareness
cognitive
experiences
modulating
MPFC.
modulation
impact
body-brain
interactions,
suggesting
therapeutic
applications.